343 related articles for article (PubMed ID: 31509643)
21. Ischemia-reperfusion injury and its relationship with early allograft dysfunction in liver transplant patients.
Ito T; Naini BV; Markovic D; Aziz A; Younan S; Lu M; Hirao H; Kadono K; Kojima H; DiNorcia J; Agopian VG; Yersiz H; Farmer DG; Busuttil RW; Kupiec-Weglinski JW; Kaldas FM
Am J Transplant; 2021 Feb; 21(2):614-625. PubMed ID: 32713098
[TBL] [Abstract][Full Text] [Related]
22. The impact of postreperfusion syndrome during liver transplantation using livers with significant macrosteatosis.
Croome KP; Lee DD; Croome S; Chadha R; Livingston D; Abader P; Keaveny AP; Taner CB
Am J Transplant; 2019 Sep; 19(9):2550-2559. PubMed ID: 30821923
[TBL] [Abstract][Full Text] [Related]
23. Analysis of dendritic cells and ischemia-reperfusion changes in postimplantation renal allograft biopsies may serve as predictors of subsequent rejection episodes.
Batal I; Mohan S; De Serres SA; Vasilescu ER; Tsapepas D; Crew RJ; Patel SS; Serban G; McCune K; Husain SA; Chang JH; Herter JM; Bhagat G; Markowitz GS; D'Agati VD; Hardy MA; Ratner L; Chandraker A
Kidney Int; 2018 May; 93(5):1227-1239. PubMed ID: 29544662
[TBL] [Abstract][Full Text] [Related]
24. The combination of indocyanine green clearance test and model for end-stage liver disease score predicts early graft outcome after liver transplantation.
Yunhua T; Weiqiang J; Maogen C; Sai Y; Zhiheng Z; Dongping W; Zhiyong G; Xiaoshun H
J Clin Monit Comput; 2018 Jun; 32(3):471-479. PubMed ID: 28831767
[TBL] [Abstract][Full Text] [Related]
25. Effect of early allograft dysfunction on outcomes following liver transplantation.
Hudcova J; Scopa C; Rashid J; Waqas A; Ruthazer R; Schumann R
Clin Transplant; 2017 Feb; 31(2):. PubMed ID: 28004856
[TBL] [Abstract][Full Text] [Related]
26. The postreperfusion syndrome is associated with acute kidney injury following donation after brain death liver transplantation.
Kalisvaart M; de Haan JE; Hesselink DA; Polak WG; Hansen BE; IJzermans JNM; Gommers D; Metselaar HJ; de Jonge J
Transpl Int; 2017 Jul; 30(7):660-669. PubMed ID: 27864895
[TBL] [Abstract][Full Text] [Related]
27. Liver Ischemia and Reperfusion Induce Periportal Expression of Necroptosis Executor pMLKL Which Is Associated With Early Allograft Dysfunction After Transplantation.
Shi S; Bonaccorsi-Riani E; Schurink I; van den Bosch T; Doukas M; Lila KA; Roest HP; Xhema D; Gianello P; de Jonge J; Verstegen MMA; van der Laan LJW
Front Immunol; 2022; 13():890353. PubMed ID: 35655777
[TBL] [Abstract][Full Text] [Related]
28. The Role of Ischemia/Reperfusion Injury in Early Hepatic Allograft Dysfunction.
Zhou J; Chen J; Wei Q; Saeb-Parsy K; Xu X
Liver Transpl; 2020 Aug; 26(8):1034-1048. PubMed ID: 32294292
[TBL] [Abstract][Full Text] [Related]
29. Acute kidney injury after orthotopic liver transplantation using living donor versus deceased donor grafts: A propensity score-matched analysis.
Hilmi IA; Damian D; Al-Khafaji A; Sakai T; Donaldson J; Winger DG; Kellum JA
Liver Transpl; 2015 Sep; 21(9):1179-85. PubMed ID: 25980614
[TBL] [Abstract][Full Text] [Related]
30. Analysis of ischemia/reperfusion injury in time-zero biopsies predicts liver allograft outcomes.
Ali JM; Davies SE; Brais RJ; Randle LV; Klinck JR; Allison ME; Chen Y; Pasea L; Harper SF; Pettigrew GJ
Liver Transpl; 2015 Apr; 21(4):487-99. PubMed ID: 25545865
[TBL] [Abstract][Full Text] [Related]
31. Impact of rifaximin use for hepatic encephalopathy on the risk of early post-transplant infections in liver transplant recipients.
Sun HY; Wagener M; Cacciarelli TV; Singh N
Clin Transplant; 2012; 26(6):849-52. PubMed ID: 22432742
[TBL] [Abstract][Full Text] [Related]
32. Is Ischemic Preconditioning a Useful Therapeutic Strategy in Liver Transplantation? Results from the First Pilot Study in Mexico.
Zapata-Chavira HA; Cordero-Pérez P; Casillas-Ramírez A; Escobedo-Villarreal MM; Pérez-Rodríguez E; Torres-González L; Camara-Lemarroy C; Hernández-Guedea MA; Caballero-Mendoza E; Muñoz-Espinosa LE
Arch Med Res; 2015 May; 46(4):296-302. PubMed ID: 26074359
[TBL] [Abstract][Full Text] [Related]
33. Donor Hepatic Steatosis Induce Exacerbated Ischemia-Reperfusion Injury Through Activation of Innate Immune Response Molecular Pathways.
Gehrau RC; Mas VR; Dumur CI; Suh JL; Sharma AK; Cathro HP; Maluf DG
Transplantation; 2015 Dec; 99(12):2523-33. PubMed ID: 26285018
[TBL] [Abstract][Full Text] [Related]
34. Predicting early allograft failure and mortality after liver transplantation: the role of the postoperative model for end-stage liver disease score.
Wagener G; Raffel B; Young AT; Minhaz M; Emond J
Liver Transpl; 2013 May; 19(5):534-42. PubMed ID: 23576469
[TBL] [Abstract][Full Text] [Related]
35. Hepatic blood flow plays an important role in ischemia-reperfusion injury.
Kelly DM; Shiba H; Nakagawa S; Irefin S; Eghtesad B; Quintini C; Aucejo F; Hashimoto K; Fung JJ; Miller C
Liver Transpl; 2011 Dec; 17(12):1448-56. PubMed ID: 21858913
[TBL] [Abstract][Full Text] [Related]
36. Human Antigen R (HuR): A Regulator of Heme Oxygenase-1 Cytoprotection in Mouse and Human Liver Transplant Injury.
Dery KJ; Nakamura K; Kadono K; Hirao H; Kageyama S; Ito T; Kojima H; Kaldas FM; Busuttil RW; Kupiec-Weglinski JW
Hepatology; 2020 Sep; 72(3):1056-1072. PubMed ID: 31879990
[TBL] [Abstract][Full Text] [Related]
37. Assessment of Anastomotic Biliary Complications in Adult Patients Undergoing High-Acuity Liver Transplant.
Kaldas FM; Korayem IM; Russell TA; Agopian VG; Aziz A; DiNorcia J; Farmer DG; Yersiz H; Hiatt JR; Busuttil RW
JAMA Surg; 2019 May; 154(5):431-439. PubMed ID: 30758485
[TBL] [Abstract][Full Text] [Related]
38. Impact of pretransplant rifaximin therapy on early post-liver transplant infections.
Esfeh JM; Hanouneh IA; Koval CE; Kovacs C; Dalal DS; Ansari-Gilani K; Confer BD; Eghtesad B; Zein NN; Menon KV
Liver Transpl; 2014 May; 20(5):544-51. PubMed ID: 24493238
[TBL] [Abstract][Full Text] [Related]
39. Diagnosis, Incidence, Predictors and Management of Postreperfusion Syndrome in Pediatric Deceased Donor Liver Transplantation: A Single-Center Study.
Zhang L; Tian M; Xue F; Zhu Z
Ann Transplant; 2018 May; 23():334-344. PubMed ID: 29773782
[TBL] [Abstract][Full Text] [Related]
40. Angiopoietin-2 inhibition prevents transplant ischemia-reperfusion injury and chronic rejection in rat cardiac allografts.
Syrjälä SO; Tuuminen R; Nykänen AI; Raissadati A; Dashkevich A; Keränen MA; Arnaudova R; Krebs R; Leow CC; Saharinen P; Alitalo K; Lemström KB
Am J Transplant; 2014 May; 14(5):1096-108. PubMed ID: 24708486
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
